VANCOUVER, British Columbia, Oct. 15, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce it has completed the commissioning of its Vitalis Extraction Technology R200H-GMP-SS extraction system. The news comes days after revealing the Company has met its first-year cannabis production forecast of 22,500 kg, which will be processed to produce premium quality extracts in the form of full-spectrum cannabis oil, distillates, isolates and terpenes.
CLC’s focus on extracting unique terpenes and cannabinoid profiles from the outdoor grown harvest answers a growing demand from a customer base interested in full-spectrum products. With flexibility, quality and safety at the core of its operations and future plans to scale, CLC chose the Vitalis R200 extractor made by Kelowna-based Vitalis Extraction Technologies.
Joel Dumaresq commented, “Extraction is an important part of our business model, thus the need for advanced specialized machinery has validated the purchase and commissioning of the Vitalis R-200. Accomplishing this key milestone has aligned with the company’s goal of bringing product to market and establishing CLC as a global leader. Furthermore, CO2-based extraction systems, such as the Vitalis R-200-H-GMP-SS (which comes with the proper certifications and qualifications), can position the Company to receive a GMP certificate from the European Union (based on current standards), which would enable CLC to export its product directly to Europe.” Since its release, the Vitalis R-Series has become renowned in the extraction industry for its speed and efficacy. At a 200-L scalable capacity, the system has been engineered to provide a wide range of pressure, and temperature controls to produce premium quality, full-spectrum extracts.
In addition to holding the Canadian Standard Association (CRN), and American Society of Mechanical Engineers (ASME) certifications, the system is EU-GMP compliant, which meets the global production standards and regulations, and positions Christina Lake Cannabis to not only serve the growing domestic market but also expand its operations as an exporter of premium quality British Columbian cannabis extract to the world.
CLC’s recent acquirement of ancillary equipment for the pre- and post-processing steps of the extraction process will also enable it to exceed its inaugural harvest by more than 200%. The additional bandwidth will allow CLC to increase its production with the option of expanding to its adjacent 99-acre property or by conducting supplementary hemp production in the form of toll processing.
“Every Vitalis system has been designed to not only meet the standards of today but in anticipation of the changing regulatory requirements around the safety, quality and consistency of the future,” commented Joel Sherlock, Vitalis Co-founder and Chairman. “We are delighted to welcome Christina Lake Cannabis to the Vitalis family and look forward to witnessing their success as a leader in the global cannabis extraction space.”
About Christina Lake Cannabis Corp.
Christina Lake Cannabis Corp is a Licensed Producer of cannabis under the Cannabis Act which also received a Research and Development License from Health Canada on May 20, 2020. CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, as well as research facilities, and a facility dedicated to processing and extraction. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and expects to produce 22,500 kg or more from its 32-acre facility before developing its adjacent 99-acre expansion property, which will bring its cultivation footprint to over 4.35 million square feet or over 88,000 kg of low-cost, high-quality, sun-grown cannabis annually.
Vitalis Extraction Technology Inc. (Vitalis) is a privately-owned, Kelowna BC-based engineering and manufacturing company, producing industrial supercritical CO2 extraction system for the cannabis, hemp, pharmaceuticals, F&B and essential oil industries. The company’s core focus on innovation and design has vaulted it to the forefront of the market. Renowned for their reliability, scalability, and continuous operation, Vitalis systems are euGMP-compliant and carry the latest certifications, including the American Society of Mechanical Engineers (ASME), National Board (NB), Canadian Standard Association (CSA/CRN), and European Conformity (CE/PED). Vitalis is one of only a few Original Equipment Manufacturers in the space, with operations in Canada, Australia, USA, Colombia, Denmark, United Kingdom, and Serbia as well as in-country support centers spread across the globe. Visit https://vitaliset.com for more information.
On behalf of Christina Lake Cannabis Corp.:
Joel Dumaresq, CEO and Director
For more information about CLC, please visit: www.clcannabis.com
THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.
PURA 1-for-1 Shareholder Dividend of PAOG Shares on Track
Dallas, Texas–(Newsfile Corp. – October 30, 2020) – PAO Group, Inc. (OTC Pink: PAOG) and Puration, Inc. (OTC: Pink: PURA) today released an update on the process underway for PAOG to issue PAOG shares to PURA shareholders in a dividend distribution.
PAOG acquired a cannabis cultivation operation from PURA earlier this year in a transaction that includes issuing PAOG shares to PURA shareholders. The target distribution ratio calls for PURA shareholders receiving one share of PAOG for every one share of PURA owned.
PAOG has executed two acquisitions in recent months and managed to ramp up and organize acquired cannabis pharmaceutical research assets as necessary to execute a contract prerequisite to developing its acquired cannabis pharmaceutical research assets into an FDA approved drug. PAOG admits the dividend distribution process has lagged behind the acquisition and pharmaceutical development contract efforts. Last week, after completing the pharmaceutical development contract, PAOG management and PURA management committed to rapidly completing the dividend issuance.
Since initiating the joint rapid dividend completion effort, PAOG has filed to redomicile the company to Wyoming and increase the authorized number of shares in order to have the necessary inventory to execute the dividend distribution. PAOG has also engaged the services of the company’s transfer agent to manage the dividend distribution of PAOG stock to PURA shareholders. Once the move to Wyoming is complete, PAOG will file with the necessary financial regulatory authority to finalize the dividend details. PAOG anticipates a definitive dividend distribution announcement will be forthcoming within the next two weeks.
PAOG is excited to make PURA shareholders also PAOG shareholders.
The developing PAOG and PURA partnership includes PAOG participating in PURA’s new hemp lifestyle brand strategy, called Farmersville Brands and headquartered on a 72-acre property currently under contract for acquisition by PURA. In conjunction with PAOG’s newly acquired cultivation business, PAOG plans to build a pharmaceutical grade, indoor hemp cultivation operation and lab on PURA’s Farmersville property.
Look for more information coming soon from both PURA and PAOG.
For more information on PAO Group, visit www.paogroupinc.com.
For more information on Puration, visit www.purationinc.com.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
PAO Group, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67197
Special Guests and Lovers of Psychedelics Are “Coming Out of the Chemical Closet” to Celebrate New Book about MDMA — Register For Virtual Book Launch
New York, New York–(Newsfile Corp. – October 30, 2020) – Charley Wininger and his publisher Inner Traditions are welcoming the arrival of his book “Listening to Ecstasy: The Transformative Power of MDMA” with a free virtual night of storytelling on Nov 13th, 7:00 PM (Eastern Time). Members of the press are invited to join this unique event. To register click link HERE.
To view an enhanced version of this graphic, please visit:
Charley will be joined by several psychedelic luminaries, and hosted by comedian Sarah Rose Siskind. They will share intimate, touching and humorous stories about a time their lives were transformed by the often misunderstood underground party drug, MDMA.
In his book, “Listening to Ecstasy” Charley reveals how MDMA has enhanced his marriage both erotically and emotionally, and describes how pleasure, fun, and joy can be profound bonding and transformative experiences.
To view an enhanced version of this graphic, please visit:
“This is also the story of how my wife and I entered a forbidden world of drug users, and found it to be enchanted. MDMA opened up our lives to new friends, fun, and freedom. It’s also helped us navigate the aging process as we transitioned from middle age into our sixties and seventies.” – Charley Wininger
Wininger’s writing and personal narrative shows how MDMA can be a tool for healing and connection. This is why this particular psychedelic compound is being studied to treat Post-Traumatic Stress Disorder (PTSD) with Phase 3, peer-reviewed trials taking place at research sites in the U.S., Canada, and Israel. (Multidisciplinary Association for Psychedelic Studies, 2020). At the current pace, MDMA will be a prescription medication in the U.S. by 2023.
In a recent Forbes article, Charley referred to MDMA as “super glue for relationships“. He and his wife are open to giving candid interviews about how MDMA helps to strengthen their connection.“It can help you connect with yourself, with your loved ones and with the world at large, [which] is especially important now when we live in a time of isolation and fear.” – Charley Wininger (Forbes)
Members of the media
- Check out the Charley Wininger Media Kit for quotes and downloadable images
- Book interview with Charley before launch (Nov. 13th)
- Request media review copy of Listening to Ecstasy
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67182
DGDM Sees Expanding Opportunity in Hemp Processing, Product Development
Flower Mound, Texas–(Newsfile Corp. – October 30, 2020) – Digital Development Partners, Inc. (OTC PINK: DGDM) (“DGDM” or the “Company”), doing business as Black Bird Potentials Inc., the exclusive distributor of MiteXstream biopesticide and manufacturer of Grizzly Creek Naturals CBD products (GrizzlyCreekNaturals.com), today discussed its Black Bird American Hemp division’s positioning in the rapidly expanding hemp industry, which, according to Grand View Research, is expected to reach approximately $5.3 billion in 2020 and over $15 billion in 2027.
Product Diversity. “While we remain committed to hemp-based protein products to target the rapidly expanding alternative meat industry, it is important to note the size of the overall hemp products market beyond that particular segment. We need not chose just one segment; we are committed to developing a wide array of hemp products,” said Fabian Deneault, President of DGDM. “The hemp market is enormous, with awareness of non-CBD hemp products accelerating rapidly, but it remains fragmented, thus providing our hemp processing division with the freedom to go after market share in several key product areas, including within the construction industry, the personal care industry and the animal care industry.”
Advisory Board Hemp Working Groups. Due to the vast potential offered by the hemp plant itself, the Company’s Board has determined to create product development working groups to be headed by members of its previously announced Advisory Board. These working groups are intended to achieve accelerated product development and market penetration strategies for the Company.
DGDM: Doing Good, Doing More. DGDM is always looking for ways to live up to its mission statement, Doing Good, Doing More.
Through its subsidiary Black Bird Potentials, DGDM manufactures and sells CBD products, including CBD Oils, gummies and pet treats, and CBD-infused personal care products, as well as hand sanitizer gel and spray products. In addition, Black Bird is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. Black Bird is the exclusive distributor in the U. S. and Canada for MiteXstream, a plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee and house plants, as well as molds and mildew. EPA approval of MiteXstream is expected in late 2020.
Notice Regarding Forward-Looking Statements
This news release contains forward-looking information including statements that include the words “believes,” “expects,” “anticipate,” or similar expressions. Such forward looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof. Information concerning these and other factors can be found in the company’s filings with the SEC, including its Forms 10-K, 10-Q, and 8-K, which can be obtained on the SEC’s website at http://www.sec.gov.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67184
Cannabis3 weeks ago
Bud & Tender® raise testing and quality standards for best CBD oil in the UK
Cannabis3 weeks ago
The World’s Greatest Weight Loss Secret May be Psilocybin
Cannabis2 weeks ago
Aither Ingredients Announces Joint Venture With Thar Process Intended to Disrupt the Canadian Cannabis-based Ingredient Market
Cannabis4 weeks ago
WeedMD Reports Second Quarter 2020 Financial Results and Closes $30 Million Credit Facility with LiUNA Pension Fund
Cannabis4 weeks ago
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND
Cannabis2 weeks ago
IGNITE Files Q2 2020 Financial Statements and MD&A
Cannabis3 weeks ago
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for World’s First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)
Cannabis2 weeks ago
Next Green Wave Sauce Carts Sell Over 100k In Under 30 Days